Literature DB >> 6774673

Gold in psoriatic arthopathy.

M B Richter, P Kinsella, M Corbett.   

Abstract

It has been suggested that gold is not effective in psoriatic arthropathy. We did not agree and therefore did a retrospective study of 98 patients. Gold had been given to 27 and was effective in 22, 14 of whom are still receiving it. The incidence of side effects was low and comparable to those in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774673      PMCID: PMC1000531          DOI: 10.1136/ard.39.3.279

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  3 in total

1.  Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis.

Authors:  V WRIGHT
Journal:  Ann Rheum Dis       Date:  1961-06       Impact factor: 19.103

2.  Rheumatism and psoriasis: a re-evaluation.

Authors:  V WRIGHT
Journal:  Am J Med       Date:  1959-09       Impact factor: 4.965

3.  Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.

Authors:  B B Dorwart; E P Gall; H R Schumacher; R E Krauser
Journal:  Arthritis Rheum       Date:  1978-06
  3 in total
  4 in total

1.  Long term experience with oral gold in psoriatic arthritis.

Authors:  P Barbieri; M L Ciompi; C Bini; G Pasero
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

Review 2.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

3.  Treatment of psoriatic arthritis with auranofin and gold sodium thiomalate.

Authors:  W Brückle; T Dexel; K Grasedyck; M Schattenkirchner
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

4.  Clinical response to auranofin in patients with psoriatic arthritis.

Authors:  C Salvarani; F Zizzi; P Macchioni; W Mantovani; F Rossi; R Baricchi; A Bellelli; N Capozzoli; L Frizziero; I Portioli
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.